RADIOACTIVE CEMENT OF PMMA AND HAP-Sm-153, Ho-166, OR RE-188 FOR BONE METASTASIS TREATMENT

Polymethylmetacrylte (PMMA) is used in the fields of dentistry and biomedicine as a constituent of bone cements. Hydroxyapatite (HAp) is a bioceramic produced naturally in the bones. PMMA and HAp are fundamental constituents in the preparation of bone cements. Bisphosphonates have also been used as...

Full description

Saved in:
Bibliographic Details
Published in:Acta ortopedica brasileira Vol. 27; no. 1; pp. 64 - 68
Main Authors: Montaño, Carlos Julio, de Campos, Tarcisio Passos Ribeiro
Format: Journal Article
Language:English
Published: Brazil ATHA EDITORA 01-01-2019
Sociedade Brasileira de Ortopedia e Traumatologia
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Polymethylmetacrylte (PMMA) is used in the fields of dentistry and biomedicine as a constituent of bone cements. Hydroxyapatite (HAp) is a bioceramic produced naturally in the bones. PMMA and HAp are fundamental constituents in the preparation of bone cements. Bisphosphonates have also been used as radiopharmaceutical in dental implants and nuclear medicine, or as palliative systemic treatment for pain reduction in bone metastasis. Vertebroplasty and kyphoplasty are bone cement-based techniques used in orthopedics, being minimally invasive procedures with low risks of infections, applied in osteoporosis and high-impact fractures. Recently, Núcleo de Radiações Ionizantes da Universidade Federal de Minas Gerais proposed a synthetic composite of M-HAp with a metallic nuclide M. After irradiation, M-HAp was added to PMMA, compounding a radioactive bone cement that can recover bone body stabilization, pasting microfractures and recomposing the anatomy and functionality of the affected parts by the compression of bone metastases, with possible pain reduction through quick radiation-induced decompression. Computational dosimetric models, and the synthesis and characterization of bioceramics that incorporate Re-188, Ho-166, or Sm-153 have demonstrated the benefits of these biometrics as promising alternative therapies, mainly from their ability to maintain the ionization in the bone structure, thereby sparing the spinal cord. This article presents a review on this topic.
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-3
content type line 23
ObjectType-Review-1
All authors declare no potential conflict of interest related to this article.
AUTHORS’ CONTRIBUTIONS: Each individual author contributed significantly to the development of the manuscript. TPRC (0000-0003-1476-3474)* and CJM (0000-0001-7125-9982)* were the main contributors in the writing of the manuscript. They facilitated the development of the bibliographical research, reviewed the manuscript, and contributed to the final manuscript. *ORCID (Open Researcher and Contributor ID).
ISSN:1413-7852
1809-4406
1809-4406
DOI:10.1590/1413-785220192701190288